Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.
Fibrosis
Histopathology
IBD
Stricture
Journal
Gastroenterology
ISSN: 1528-0012
Titre abrégé: Gastroenterology
Pays: United States
ID NLM: 0374630
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
received:
24
04
2019
revised:
29
07
2019
accepted:
22
08
2019
pubmed:
3
9
2019
medline:
15
2
2020
entrez:
3
9
2019
Statut:
ppublish
Résumé
Stenosis is a common complication of Crohn's disease (CD) that has no effective medical therapy. Development of antifibrotic agents will require testing in randomized controlled trials. Computed tomography enterography- and magnetic resonance enterography-based technologies might be used to measure outcomes in these trials. These approaches have been validated in studies of patients with symptomatic strictures who underwent imaging evaluations followed by resection with histopathologic grading of the intestinal tissue for inflammation and/or fibrosis (the reference standard). Imaging findings have correlated with findings from quantitative or semiquantitative histologic evaluation of the degree of fibromuscular stenosis and/or inflammation on the resection specimen. However, it is not clear whether histologic findings are an accurate reference standard. We performed a systematic review of all published histologic scoring systems used to assess stenosing CD. We performed a comprehensive search of Embase and MEDLINE of studies through March 13, 2019, that used a histologic scoring system to characterize small bowel CD and assessed inflammatory and fibrotic alterations within the same adult individual. All scores fitting the criteria were included in our analysis, independent of the presence of stricturing disease, as long as inflammation and fibrosis were evaluated separately but in the same scoring system. We observed substantial heterogeneity among the scoring systems, which were not derived from modern principles for evaluative index development. None had undergone formal validity or reliability testing. None of the existing indices had been constructed according to accepted methods for the development of evaluative indices. Basic knowledge regarding their operating properties were lacking. Specific indices for evaluating the important pathologic component of myofibroblast hypertrophy or hyperplasia have not been proposed. In a systematic review of publications, we found a lack of validated histopathologic scoring systems for assessment of fibromuscular stenosis. Data that describe the operating properties of existing cross-sectional imaging techniques for stenosing CD should be questioned. Development and validation of a histopathology index is an important research priority.
Sections du résumé
BACKGROUND & AIMS
Stenosis is a common complication of Crohn's disease (CD) that has no effective medical therapy. Development of antifibrotic agents will require testing in randomized controlled trials. Computed tomography enterography- and magnetic resonance enterography-based technologies might be used to measure outcomes in these trials. These approaches have been validated in studies of patients with symptomatic strictures who underwent imaging evaluations followed by resection with histopathologic grading of the intestinal tissue for inflammation and/or fibrosis (the reference standard). Imaging findings have correlated with findings from quantitative or semiquantitative histologic evaluation of the degree of fibromuscular stenosis and/or inflammation on the resection specimen. However, it is not clear whether histologic findings are an accurate reference standard. We performed a systematic review of all published histologic scoring systems used to assess stenosing CD.
METHODS
We performed a comprehensive search of Embase and MEDLINE of studies through March 13, 2019, that used a histologic scoring system to characterize small bowel CD and assessed inflammatory and fibrotic alterations within the same adult individual. All scores fitting the criteria were included in our analysis, independent of the presence of stricturing disease, as long as inflammation and fibrosis were evaluated separately but in the same scoring system.
RESULTS
We observed substantial heterogeneity among the scoring systems, which were not derived from modern principles for evaluative index development. None had undergone formal validity or reliability testing. None of the existing indices had been constructed according to accepted methods for the development of evaluative indices. Basic knowledge regarding their operating properties were lacking. Specific indices for evaluating the important pathologic component of myofibroblast hypertrophy or hyperplasia have not been proposed.
CONCLUSIONS
In a systematic review of publications, we found a lack of validated histopathologic scoring systems for assessment of fibromuscular stenosis. Data that describe the operating properties of existing cross-sectional imaging techniques for stenosing CD should be questioned. Development and validation of a histopathology index is an important research priority.
Identifiants
pubmed: 31476299
pii: S0016-5085(19)41258-4
doi: 10.1053/j.gastro.2019.08.033
pmc: PMC7649049
mid: NIHMS1637070
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-150.e1Subventions
Organisme : NIDDK NIH HHS
ID : K08 DK110415
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Références
Am J Clin Pathol. 1977 Jun;67(6):550-4
pubmed: 868794
Fibrogenesis Tissue Repair. 2014 Mar 29;7(1):5
pubmed: 24678903
Circulation. 2002 May 28;105(21):2512-7
pubmed: 12034658
Am J Gastroenterol. 2007 Nov;102(11):2541-50
pubmed: 17900329
Dis Colon Rectum. 1991 Oct;34(10):909-16
pubmed: 1914726
Gastroenterology. 2017 Feb;152(2):322-326
pubmed: 27729212
Aliment Pharmacol Ther. 2018 Aug;48(3):347-357
pubmed: 29920726
J Ultrasound Med. 2014 Dec;33(12):2115-23
pubmed: 25425367
Inflamm Bowel Dis. 2012 May;18(5):849-56
pubmed: 21710535
J Clin Epidemiol. 1992 Dec;45(12):1341-5
pubmed: 1460470
Inflamm Bowel Dis. 2016 Sep;22(9):2280-8
pubmed: 27508513
Am J Physiol Gastrointest Liver Physiol. 2000 Dec;279(6):G1307-22
pubmed: 11093955
Inflamm Bowel Dis. 2015 Feb;21(2):468-75
pubmed: 25437814
J Crohns Colitis. 2018 Nov 9;12(10):1139-1150
pubmed: 29309546
Gastroenterology. 2018 Jul;155(1):76-87
pubmed: 29601825
Am J Gastroenterol. 2007 Feb;102(2):439-48
pubmed: 17156147
Best Pract Res Clin Gastroenterol. 2014 Jun;28(3):497-503
pubmed: 24913388
Mod Pathol. 2003 Apr;16(4):347-58
pubmed: 12692200
Clin Gastroenterol Hepatol. 2011 Feb;9(2):124-9
pubmed: 21056692
J Chronic Dis. 1987;40(2):171-8
pubmed: 3818871
Radiology. 2010 Mar;254(3):755-64
pubmed: 20177090
Hum Pathol. 2018 Sep;79:42-49
pubmed: 29555578
Inflamm Bowel Dis. 2013 Jul;19(8):1745-52
pubmed: 23782793
Aliment Pharmacol Ther. 2018 Apr;47(7):922-939
pubmed: 29411405
Radiology. 2015 Jun;275(3):889-99
pubmed: 25668520
Am J Physiol. 1992 Jun;262(6 Pt 1):G1041-6
pubmed: 1616034
Inflamm Bowel Dis. 2017 Jan;23(1):133-142
pubmed: 28002130
J Crohns Colitis. 2018 May 25;12(6):718-729
pubmed: 29300851
Eur J Radiol. 2012 Sep;81(9):2080-8
pubmed: 21924572
Am J Respir Crit Care Med. 2004 May 1;169(9):1001-6
pubmed: 14726423
J Chronic Dis. 1985;38(1):27-36
pubmed: 3972947
J Crohns Colitis. 2016 Aug;10(8):873-85
pubmed: 26928961
Int J Surg. 2015 Mar;15:49-54
pubmed: 25647540
Histopathology. 2006 Jan;48(2):116-32
pubmed: 16405661
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2514-2522.e8
pubmed: 30503966
Arch Pathol Lab Med. 2001 Oct;125(10):1331-4
pubmed: 11570909
Virchows Arch. 2003 Oct;443(4):501-7
pubmed: 12898246
Inflamm Bowel Dis. 2019 Feb 21;25(3):421-426
pubmed: 30346528
Gastroenterology. 1988 Feb;94(2):257-65
pubmed: 3335305
Lancet. 2011 May 21;377(9779):1760-9
pubmed: 21571362
Lancet. 2017 Apr 29;389(10080):1741-1755
pubmed: 27914655
Am J Nephrol. 2003 Sep-Oct;23(5):300-6
pubmed: 12904684
J Crohns Colitis. 2017 Feb;11(2):212-220
pubmed: 27466173
Am J Gastroenterol. 2015 Mar;110(3):432-40
pubmed: 25623654
Eur Radiol. 2014 Mar;24(3):619-29
pubmed: 24037299
Inflamm Bowel Dis. 2015 Oct;21(10):2429-40
pubmed: 26218140
Aliment Pharmacol Ther. 2003 Oct 1;18(7):749-56
pubmed: 14510749
J Crohns Colitis. 2013 Mar;7(2):120-8
pubmed: 22483566
Inflamm Bowel Dis. 2011 Apr;17(4):984-93
pubmed: 20722053
Radiology. 2016 Mar;278(3):792-800
pubmed: 26436860
Lancet. 2009 Apr 11;373(9671):1264-74
pubmed: 19362676
Ultraschall Med. 2011 Apr;32(2):154-9
pubmed: 20449794
J Crohns Colitis. 2016 Mar;10(3):277-85
pubmed: 26574490
Radiology. 2009 Sep;252(3):712-20
pubmed: 19635832
Gastroenterology. 2006 May;130(6):1595-606
pubmed: 16697723
J Crohns Colitis. 2017 Jan;11(1):92-104
pubmed: 27364949
Gut. 2019 Jun;68(6):1115-1126
pubmed: 30944110
Proc Natl Acad Sci U S A. 1981 Dec;78(12):7759-63
pubmed: 6950415
Gut. 2009 Sep;58(9):1218-25
pubmed: 19625280
J Crohns Colitis. 2018 Jan 5;12(1):48-56
pubmed: 28981627
J Nucl Med. 2009 Nov;50(11):1751-9
pubmed: 19837758
Gastroenterology. 2017 Feb;152(2):340-350.e6
pubmed: 27720839
Br J Surg. 1995 Feb;82(2):191-4
pubmed: 7749686